Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220007236 220018890 1.67 83.7 Curative (C) 2013-01-13 2013-01-18 AML 18 TRIAL N Y 220031971 AML18 TRIAL
220007237 220018890 1.75 0 null 2017-10-23 2017-10-23 Dasatinib 2 N 220031971 DASATINIB
220007238 220022012 1.8 141 Palliative (P) 2016-09-09 2016-09-13 Cisplatin + Gemcitabine (D 1 & 8) 02 N 220031979 CISPLATIN + GEMCITABINE
220007239 220002828 1.69 null null 2013-10-20 2013-10-24 AML16 DA 3+10 Y N 220031981 AML16 TRIAL
220007240 220002829 1.75 null Palliative (P) 2017-10-19 2017-09-22 Carboplatin + Paclitaxel (3 weekly) 2 N 220031982 CARBOPLATIN + PACLITAXEL
220007241 220002829 1.92 84 null 2014-11-01 2014-11-02 CISPLATIN + GEMCITABINE 02 N 220031982 CISPLATIN + GEMCITABINE
220007242 220016247 1.82 98.1 Palliative (P) 2018-06-11 2018-06-11 Dasatinib N N 220031987 DASATINIB
220007245 220002830 1.7 93.2 Palliative (P) null 2014-04-16 GemCarbo Days 1+8 N N 220031992 GEMCARBO
220007247 220002832 1.63 44.9 null 2016-01-12 2016-04-26 GemCarbo Days 1+8 02 N 220031995 GEMCARBO
220007248 220002833 1.67 77.2 Curative (C) 2014-03-30 2014-03-31 AML18 PILOT TRIAL 1 N 220031997 PILOT TRIAL
220007249 220011612 1.56 72.6 Curative (C) 2015-09-14 2015-09-14 AML16 DA 3+10 N N 220031998 AML16 TRIAL
220007250 220002834 1.61 null Curative (C) 2013-10-14 2013-10-14 AML18 PILOT TRIAL N N 220032001 PILOT TRIAL
220007251 220002835 1.56 69.6 Disease modification (D) 2017-07-09 2017-07-17 AML16 Low Dose Cytarabine N N 220032004 AML16 TRIAL
220007252 220002835 1.67 66.5 Curative (C) 2017-04-23 2017-04-24 IDARUBICIN + TRETINOIN N N 220032004 IDARUBICIN + TRETINOIN
220007253 220002835 null 87 Palliative (P) 2014-12-04 2014-12-11 Carboplatin + Paclitaxel (3 weekly) 2 N 220032004 CARBOPLATIN + PACLITAXEL
220007254 220002835 1.7 80 Curative (C) 2017-11-29 2017-11-29 AML 18 TRIAL 1 null 220032004 AML18 TRIAL
220007255 220002836 1.65 67.4 null null 2014-03-27 AML16 Azacitidine 02 null 220032009 AML16 TRIAL
220007256 220011614 1.76 82.5 Palliative (P) 2016-11-26 2017-03-12 GemCarbo Days 1+8 N null 220032012 GEMCARBO
220007259 220016249 1.76 95 null 2014-07-05 2014-07-08 Dasatinib 02 null 220032022 DASATINIB
220007260 220002838 1.73 59.7 Curative (C) 2016-02-09 2016-02-10 IDARUBICIN + TRETINOIN N N 220032025 IDARUBICIN + TRETINOIN
220007261 220002839 1.64 82.95 Curative (C) 2017-12-17 2017-12-17 Carboplatin + Paclitaxel (3 weekly) 02 N 220032026 CARBOPLATIN + PACLITAXEL
220007262 220002840 1.66 54.8 Curative (C) 2014-09-07 2014-09-11 AML 18 Pilot Trial N N 220032027 PILOT TRIAL
220007263 220002840 1.7 95 Curative (C) 2015-02-16 2015-02-16 Dasatinib 02 N 220032027 DASATINIB
220007264 220002841 1.62 92.9 Curative (C) 2016-12-17 2016-12-17 AML18 PILOT TRIAL Y N 220032029 PILOT TRIAL
220007265 220002842 1.67 68.8 Disease modification (D) 2016-07-03 2016-07-03 Dasatinib N N 220032032 DASATINIB
220007266 220002842 1.83 83.3 Palliative (P) null 2015-11-03 Carboplatin + Paclitaxel (3 weekly) N N 220032032 CARBOPLATIN + PACLITAXEL
220007267 220002843 1.65 null Disease modification (D) 2013-02-20 2013-02-22 AML16 DA 3+10 N N 220032036 AML16 TRIAL
220007268 220002843 null 78.7 Curative (C) 2013-02-13 2013-02-13 AML18 PILOT TRIAL 1 N 220032036 PILOT TRIAL
220007269 220002844 1.8 64.7 Curative (C) 2015-07-13 2016-08-14 AML18 PILOT TRIAL Y N 220032039 PILOT TRIAL
220007270 220002845 1.75 null Palliative (P) 2017-06-12 2017-07-24 Cisplatin + Gemcitabine (D 1 & 8) 2 Y 220032041 CISPLATIN + GEMCITABINE
220007271 220011619 1.67 59.8 Palliative (P) 2015-08-18 2015-08-18 Cisplatin + Gemcitabine (D 1 & 8) N null 220032042 CISPLATIN + GEMCITABINE
220007272 220002846 1.7 69.6 Palliative (P) 2016-08-08 2016-08-21 GemCarbo Days 1+8 N N 220032045 GEMCARBO
220007273 220002846 1.88 88.4 Disease modification (D) 2016-02-14 2016-02-14 Dasatinib 02 N 220032045 DASATINIB
220007274 220002846 1.78 null Curative (C) 2014-09-02 2014-09-04 Idarubicin+Tretinoin Spanish Crse1 N N 220032045 IDARUBICIN + TRETINOIN
220007275 220002846 1.87 null null 2017-05-14 2017-05-14 AML 18 TRIAL Y N 220032045 AML18 TRIAL
220007276 220002846 1.63 65 Palliative (P) 2016-01-20 2016-01-20 Cisplatin + Gemcitabine (D 1 & 8) 02 N 220032045 CISPLATIN + GEMCITABINE
220007277 220002847 1.74 95.6 Curative (C) 2014-10-12 2014-10-13 AML 18 TRIAL Y N 220032056 AML18 TRIAL
220007278 220002847 1.6 0 Curative (C) 2013-01-31 2013-01-31 AML 18 TRIAL 01 N 220032056 AML18 TRIAL
220007279 220002848 1.6 65 Curative (C) 2018-01-02 2018-01-02 AML18 PILOT TRIAL null N 220032061 PILOT TRIAL
220007281 220002849 null null Disease modification (D) 2017-06-06 2017-06-06 Dasatinib N N 220032064 DASATINIB
220007282 220002849 1.62 90 Curative (C) 2014-07-05 2014-07-05 IDARUBICIN + TRETINOIN null null 220032064 IDARUBICIN + TRETINOIN
220007283 220002849 1.65 78 Curative (C) 2014-12-18 2015-01-10 Carboplatin + Paclitaxel (weekly) 02 N 220032064 CARBOPLATIN + PACLITAXEL
220007284 220002850 1.57 47.2 Disease modification (D) 2016-09-25 2016-10-05 AML16 DA 3+8 N N 220032072 AML16 TRIAL
220007285 220002850 null 83.5 Palliative (P) 2014-12-11 2014-12-20 GemCarbo Days 1+8 02 N 220032072 GEMCARBO
220007286 220002850 1.8 84.5 Curative (C) 2015-07-06 2015-07-06 AML16 DA 3+10 N null 220032072 AML16 TRIAL
220007287 220002850 1.57 null Curative (C) 2015-03-27 2015-03-31 AML 18 TRIAL Y N 220032072 AML18 TRIAL
220007288 220002850 1.76 77 Curative (C) 2017-10-17 2017-10-17 Dasatinib N N 220032072 DASATINIB
220007289 220021278 null 68.3 Neo-adjuvant (N) 2017-02-21 2017-02-22 CARBOPLATIN + PACLITAXEL 02 N 220032092 CARBOPLATIN + PACLITAXEL
220007291 220002852 1.59 55.2 Palliative (P) 2015-10-26 2015-11-03 GemCarbo Days 1+8 2 N 220032095 GEMCARBO
220007292 220002853 null 90 Not known (9) 2017-02-28 2017-02-28 Idarubicin+Tretinoin Spanish Crse1 N N 220032096 IDARUBICIN + TRETINOIN